Evaluation of antimicrobial activity and cytotoxicity of pegylated aminoglycosides
Source abstract
Abstract
Here, in this study, we have investigated the antibacterial activity and cytotoxicity of pegylated aminoglycosides (gentamicin, kanamycin, and neomycin). The antibacterial activity of pegylated aminoglycosides, prepared in two different ratios (1:1 and 1:2, aminoglycoside:polyethylene glycol), was determined against some common pathogens, namely, Gram-positive ( Bacillus cereus, Staphylococcus aureus) and Gram-negative ( Escherichia coli, Pseudomonas aeruginosa), by zone of inhibition and minimum inhibitory concentration assays. The activity of pegylated aminoglycosides was found to be decreased as compared to their respective native aminoglycosides. Moreover, aminoglycoside:polyethylene glycol (1:1) derivatives showed much higher activity as compared to aminoglycoside:polyethylene glycol (1:2) derivatives, that is, an increase in the content of polyethylene glycol decreased the activity considerably. This decrease in antibacterial activity was found to be the most prominent in Gram-positive bacteria, S. aureus. On the other hand, pegylation significantly decreased the cytotoxicity as determined by hemolysis and MTT assays. These results advocate exploration of different types of crosslinkers consisting of a small degree of amphiphilicity, which could facilitate better interactions with the bacterial cell membranes and inhibit induction of bacterial resistance.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Antimicrobial agents and applications · Antimicrobial Peptides and Activities · Pharmaceutical and Antibiotic Environmental Impacts
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Nucleic Acids Research Laboratory, CSIR-Institute of Genomics and Integrative Biology, Delhi, India
Microbial Technology Laboratory, CSIR-Institute of Genomics and Integrative Biology, New Delhi, India
Funding
Council for Scientific and Industrial Research
References (54)
Show source-provided references
1. 10.4137/PMC.S1445910.4137/PMC.S14459 ↗
2. 10.1128/MMBR.00016-1010.1128/MMBR.00016-10 ↗
3. 10.1146/annurev.biochem.78.082907.14592310.1146/annurev.biochem.78.082907.145923 ↗
4. 10.1016/j.arcmed.2005.06.00910.1016/j.arcmed.2005.06.009 ↗
5. 10.1016/j.medmal.2016.10.00310.1016/j.medmal.2016.10.003 ↗
6. 10.1155/2014/54134010.1155/2014/541340 ↗
7. 10.1016/j.watres.2013.01.02010.1016/j.watres.2013.01.020 ↗
8. 10.1016/j.cld.2013.07.00810.1016/j.cld.2013.07.008 ↗
9. 10.1016/j.addr.2014.02.00210.1016/j.addr.2014.02.002 ↗
10. 10.1039/C5NJ00007F10.1039/C5NJ00007F ↗
11. 10.1016/j.ijantimicag.2014.09.01110.1016/j.ijantimicag.2014.09.011 ↗
12. 10.1016/B978-0-7020-6285-8.00143-X10.1016/B978-0-7020-6285-8.00143-X ↗
13. 10.1016/j.jcf.2013.11.00710.1016/j.jcf.2013.11.007 ↗
14. 10.1016/j.jconrel.2003.12.00510.1016/j.jconrel.2003.12.005 ↗
15. 10.1016/j.ejps.2016.03.01810.1016/j.ejps.2016.03.018 ↗
16. 10.1016/j.bcp.2014.05.01810.1016/j.bcp.2014.05.018 ↗
17. 10.1016/j.addr.2006.07.02810.1016/j.addr.2006.07.028 ↗
18. 10.1016/S0272-6386(99)70102-210.1016/S0272-6386(99)70102-2 ↗
19. 10.1016/j.taap.2007.05.00410.1016/j.taap.2007.05.004 ↗
20. 10.1016/0378-4274(89)90121-510.1016/0378-4274(89)90121-5 ↗
21. 10.1038/ki.1980.17510.1038/ki.1980.175 ↗
22. 10.1016/j.bbrc.2016.12.05210.1016/j.bbrc.2016.12.052 ↗
23. 10.1179/joc.2001.13.5.46110.1179/joc.2001.13.5.461 ↗
24. 10.1016/S1359-6446(05)03552-X10.1016/S1359-6446(05)03552-X ↗
25. 10.2174/13816120777931373110.2174/138161207779313731 ↗
26. 10.1111/j.1749-6632.1999.tb08639.x10.1111/j.1749-6632.1999.tb08639.x ↗
27. 10.1016/S0272-2712(18)30572-910.1016/S0272-2712(18)30572-9 ↗
28. 10.1136/thx.2009.13153210.1136/thx.2009.131532 ↗
29. 10.1007/s00253-010-2920-910.1007/s00253-010-2920-9 ↗
30. 10.2174/156802661566615033011060210.2174/1568026615666150330110602 ↗
31. 10.1002/cmdc.20110040410.1002/cmdc.201100404 ↗
32. 10.1002/adhm.20140041810.1002/adhm.201400418 ↗
33. 10.3390/ijms1405990610.3390/ijms14059906 ↗
34. 10.1002/1097-4628(20000801)77:5<1077::AID-APP15>3.0.CO;2-Q10.1002/1097-4628(20000801)77:5<1077::AID-APP15>3.0.CO;2-Q ↗
35. 10.1002/pola.1032510.1002/pola.10325 ↗
36. 10.1039/C4TB00657G10.1039/C4TB00657G ↗
37. 10.1177/088391150303538510.1177/0883911503035385 ↗
38. 10.1177/088391151556900710.1177/0883911515569007 ↗
39. 10.1021/bm050850c10.1021/bm050850c ↗
40. 10.1186/1752-153X-6-11110.1186/1752-153X-6-111 ↗
41. 10.1021/cb100413w10.1021/cb100413w ↗
42. 10.1177/088391151562747310.1177/0883911515627473 ↗
43. 10.1080/00914037.2014.88624610.1080/00914037.2014.886246 ↗
44. 10.1155/2010/82634310.1155/2010/826343 ↗
45. 10.1016/j.actbio.2012.07.01510.1016/j.actbio.2012.07.015 ↗
46. 10.1016/j.jconrel.2013.10.00610.1016/j.jconrel.2013.10.006 ↗
47. 10.1016/j.addr.2007.02.00110.1016/j.addr.2007.02.001 ↗
48. 10.1007/s12010-015-1723-y10.1007/s12010-015-1723-y ↗
49. 10.1021/bc700264g10.1021/bc700264g ↗
50. 10.1021/bc900553n10.1021/bc900553n ↗
51. 10.1007/s12010-015-1820-y10.1007/s12010-015-1820-y ↗
52. 10.1046/j.1471-4159.2002.01160.x10.1046/j.1471-4159.2002.01160.x ↗
53. 10.1016/j.apsusc.2016.06.04210.1016/j.apsusc.2016.06.042 ↗
54. 10.1016/j.msec.2017.05.00610.1016/j.msec.2017.05.006 ↗